Vercellini, Paolo

No ORCID on file · 9 papers in corpus · active 2018-2022

Study types

  • article 6
  • other 3

Condition tags

  • endometriosis 9
  • chronic_pelvic_pain 2
other
(no title)

The role of sex steroid hormones in reproductive function in women is well established. However, in the last two decades it has been shown that receptors for estrogens, progesterone and androgens are expressed in non reproductive tissue /or…

article 2022
“Better late than never but never late is better”, especially in young women. A multicenter Italian study on diagnostic delay for symptomatic endometriosis
·doi:10.6084/m9.figshare.21401473

The aim of the study was to assess the length of diagnostic delay of symptomatic endometriosis in Italy and analyse the presence of correlations between the socio-demographic status of patients and the clinical characteristics/type of diagn…

article 2022
“Better late than never but never late is better”, especially in young women. A multicenter Italian study on diagnostic delay for symptomatic endometriosis
·doi:10.6084/m9.figshare.21401473.v1

The aim of the study was to assess the length of diagnostic delay of symptomatic endometriosis in Italy and analyse the presence of correlations between the socio-demographic status of patients and the clinical characteristics/type of diagn…

other 2018
Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain?
·doi:10.25384/sage.c.4070606.v1

The purpose of this study was to assess the proportion of patients satisfied with their treatment after a change from a low-dose oral contraceptive (OC) to norethisterone acetate (NETA) because of inefficacy of OC on pain symptoms. To this …

other 2018
Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain?
·doi:10.25384/sage.c.4070606

The purpose of this study was to assess the proportion of patients satisfied with their treatment after a change from a low-dose oral contraceptive (OC) to norethisterone acetate (NETA) because of inefficacy of OC on pain symptoms. To this …

article 2018
Supplemental Material, Supplemental_Table_1 - Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain?
·doi:10.25384/sage.6144434.v1

Supplemental Material, Supplemental_Table_1 for Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain? by Paolo Vercellini, Federica Ottolini, Maria Pina Frattaruolo, Laura Buggio…

article 2018
Supplemental Material, Supplemental_Table_1 - Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain?
·doi:10.25384/sage.6144434

Supplemental Material, Supplemental_Table_1 for Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain? by Paolo Vercellini, Federica Ottolini, Maria Pina Frattaruolo, Laura Buggio…

article 2018
Supplemental Material, Supplemental_Table_2 - Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain?
·doi:10.25384/sage.6144437

Supplemental Material, Supplemental_Table_2 for Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain? by Paolo Vercellini, Federica Ottolini, Maria Pina Frattaruolo, Laura Buggio…

article 2018
Supplemental Material, Supplemental_Table_2 - Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain?
·doi:10.25384/sage.6144437.v1

Supplemental Material, Supplemental_Table_2 for Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain? by Paolo Vercellini, Federica Ottolini, Maria Pina Frattaruolo, Laura Buggio…